BRAF and melanoma: For example, scRNA-seq of BRAF-mutant melanoma cells treated with the BRAF inhibitor vemurafenib, alone or in combination with MEK inhibitor cobimetinib or trametinib, showed seven separate cell clusters representative of distinct transcriptional states.